Topoisomerase IIa gene amplification predicts favorable outcome of tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2 positive breast cancer. Results from the randomized trial SBG 9401.

Research output: Contribution to journalPublished meeting abstract

Details

Authors
  • MM Tanner
  • JJ Isola
  • T Wiklund
  • B Erikstein
  • P Kellokumpu-Lehtinen
  • Per Malmström
  • N Wilking
  • J Nilsson
  • J Bergh
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)841S-841S
JournalJournal of Clinical Oncology
Volume23
Issue number16S
Publication statusPublished - 2005
Publication categoryResearch
Peer-reviewedYes
Event2005 ASCO Annual Meeting -
Duration: 0001 Jan 2 → …